EuroFlow Overview

  • Founded
  • 2005
Founded
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Investors
  • 2

EuroFlow General Information

Description

Developer of a diagnostics platform intended to improve the quality of diagnostics in the field of hemato-oncology worldwide. The company's platform offer development and standardization of fast and sensitive flow cytometric tests for diagnosis and prognostic classification of hematological malignancies as well as for the evaluation of treatment effectiveness during follow-up, enabling medical experts to offer treatment through advanced and developed medical technologies to ensure a faster recovery.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Primary Office
  • LUMC Building 1
  • Postal zone E3-Q, Albinusdreef 2
  • 2333 ZA Leiden
  • Netherlands
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EuroFlow Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2009 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view EuroFlow’s complete valuation and funding history, request access »

EuroFlow Board Members (7)

Name Representing Role Since
A. Orfao EuroFlow Co-Chairman 000 0000
A.E. Sousa Self Board Member 000 0000
J. Philippé Self Board Member 000 0000
J.J.M. van Dongen Self Co-Chairman 000 0000
M. Brüggemann Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

EuroFlow Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
European Commission Government 000 0000 000000 0
Catalyst Venture Partners Venture Capital Minority 000 0000 000000 0
To view EuroFlow’s complete investors history, request access »